What distinguishes the asthmatic amongst the infant wheezers?

Pediatric Allergy and Immunology, Supplement

Volumn 8, Issue 10, 1997, Pages 40-45

  Carlsen, Kai Håkon ^a  

^a Res Inst Children's Asthma A   (Norway)

Author keywords

Asthma; Atopy; Infants; Inflammatory markers; Lung function; Respiratory virus infections; Wheeze

Indexed keywords

ASTHMA; ATOPY; CONFERENCE PAPER; HUMAN; LUNG FUNCTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; VIRUS INFECTION; WHEEZING;

AGE FACTORS; ASTHMA; DIAGNOSIS, DIFFERENTIAL; HUMANS; INFANT; INFANT, NEWBORN; RESPIRATORY SOUNDS; RESPIRATORY TRACT INFECTIONS;

EID: 0031445023     PISSN: 09065784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (49)

1. CARLSEN KH, LARSEN S, ØRSTAVIK I. Acute bronchiolitis in infancy. The relationship to later obstructive airways disease and characterization of infants at risk. Eur J Respir Dis 1987: 70: 86-92.
2. MOK JYQ, SIMPSON H. Outcome for acute bronchitis, bronchiolitis and pneumonia in infancy. Arch Dis Child 1984: 59: 306-9.
3. LUYT DK, BURTON P, BROOKE AM, SIMPSON H. Wheeze in preschool children and its relation with doctor diagnosed asthma. Arch Dis Child 1994: 71: 24-30.
4. MARTINEZ FD, WRIGHT AL, TAUSSIG LM, HOLBERG CJ, HALONEN M, MORGAN WJ, The Group of Health Medical Associates. Asthma and wheezing in the first six years of life. N Engl J Med 1995: 332: 133-8.
5. AGERTOFT L, PEDERSEN S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994: 88: 373-81.
6. KÖNIG P, SCHAFFER J. The effect of drug therapy on long-term outcome of childhood asthma: A possible preview of the international guidelines. J Allergy Clin Immunol 1996: 98: 1103-11.
7. IKURA Y, NASPITZ CK, MIKAWA H, IIKURA Y, TALARICOFICHO S, BABA M, et al. Prevention of asthma by ketotifen in infants with atopic dermatitis. Ann Allergy 1992: 68: 233-6.
8. BUSTOS GJ, BUSTOS D, BUSTOS GJ, ROMERO O. Prevention of asthma with ketotifen in preasthmatic children: a three year follow-up study. Clin Exp Allergy 1995: 25: 568-73.
9. AAS K. Heterogeneity of childhood asthma. Allergy 1981: 36: 3-14.
10. BRASHER GW. Clinical aspects of infantile asthma. Ann Allergy 1975: 35: 216-20.
11. TABACHNIK E, LEVISON H. Infantile bronchial asthma. J Allergy Clin Immunol 1981: 67: 339-47.
12. CARLSEN KH, ØRSTAVIK I, HALVORSEN K. Respiratory syncytial viral infections in Oslo 1972-1978. II. Clinical and laboratory studies. Acta Paediatr Scand 1980: 69: 723-9.
13. KORPPI M, KUIKKA L, REIJONEN T, REMES K, JUNTUNEN-BACKMAN K, LAUNIALA K. Bronchial asthma and hyperreactivity after early childhood bronchiolitis or pneumonia. An 8-year follow-up study. Arch Pediatr & Adolesc Med 1994: 148: 1079-84.
14. BOESEN I. Asthmatic bronchitis in children. Acta Paediatr Scand 1953: 42: 87-96.
15. FOUCARD T, SJÖBERG O. A prospective 12-year follow-up study of children with wheezy bronchitis. Acta Paediatr Scand 1984: 73: 577-83.
16. PULLAN CR, HEY EN. Wheezing, asthma and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. B M J 1982: 284: 1665-9.
17. MCCONNOCHIE KM, ROUGHMANN KJ. Wheezing at 8 and 13 years: changing importance of bronchiolitis and passive smoking. Pediatr Pulmonol 1989: 6: 138-46.
18. CARLSEN KH, ØRSTAVIK I, HALVORSEN K. Viral infections of the respiratory tract in hospitalized children. A study from Oslo during a 90 months' period. Acta Paediatr Scand 1983: 72: 53-8.
19. SIGURS N, BJARNASON R, SIGURBERGSSON F, KJELLMAN B, BJÖRKSTÉN B. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: A prospective cohort study with matched controls. Pediatrics 1995: 95: 500-5.
20. KATTAN M, KEENS TG, LAPIERRE JG, LEVISON H, BRYAN AC, REILLY BJ. Pulmonary function abnormalities in symptom-free children after bronchiolitis. Pediatrics 1977: 59: 683-8.
21. STROPE GL, STEWART PW, HENDERSON FW, IVINS SS, STEDMAN HC, HENRY MM. Lung function in school-age children who had mild lower respiratory illnesses in early childhood. Am Rev Respir Dis 1991: 144: 655-62.
22. SHAHEEN SO, BARKER DJP, SHELL AW, CROCKER FJ, WIELD GA, HOLGATE ST. The relationship between pneumonia in early childhood and impaired lung function in late adult life. Am J Respir Crit Care Med 1994: 149: 616-19.
23. CARLSEN KH, ØRSTAVIK I, LEEGAARD J, HØEG H. Respiratory virus infections and aeroallergens in acute bronchial asthma. Arch Dis Child 1984: 59: 310-15.
24. JOHNSTON SL, PATTEMORE PK, SANDERSON G, SMITH S, LAMPE F, JOSEPHS L, et al. Community study of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995: 310: 1225-9.
25. GREVE JM, DAVIS G, MEYER AM, FORTE CP, YOST SC, MARLOR CW, et al. The major human rhinovirus receptor is ICAM-I. Cell 1989: 56: 839-47.
26. MARTINEZ FD, MORGAN WJ, WRIGHT AL, HOLBERG CJ, TAUSSIG LM. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med 1988: 319: 1112-17.
27. MARTINEZ FD, MORGAN WJ, WRIGHT AL, HOLBERG C, TAUSSIG LM. Initial airway function is a risk factor for recurrent wheezing respiratory illnesses during the first three years of life. Group Health Medical Associates. Am Rev Respir Dis 1991: 143: 312-16.
28. YOUNG S, ARNOTT J, LE SOUEF PN, LANDAU LI, LE SOUËF PN. Flow limitation during tidal expiration in symptom-free infants and the subsequent development of asthma. J Pediatr 1994: 124: 681-8.
29. TAGER IB, HANRAHAN JP, TOSTESON TD, CASTILE RG, BROWN RW, WEISS ST, et al. Lung function, pre- and postnatal smoke exposure, wheezing in the first year of life. Am Rev Respir Dis 1993: 147: 811-17.
30. LØDRUP CARLSEN KC, JAAKKOLA JJ, NAFSTAD P, CARLSEN KH. In-utero exposure to cigarette smoking influences lung function at birth. Eur Respir J 1997: 10: 1774-9.
31. SEIDMAN DS, LAOR A, GALE R, STEVENSON DK, DANON YL. Is low birth weight a risk factor for asthma during adolescence? Arch Dis Child 1991: 66: 584-7.
32. VON MUTIUS E, NICOLAI T, MARTINEZ FD. Prematurity as a risk factor for asthma in preadolescent children. J Pediatr 1993: 123: 223-9.
33. HATTEVIG G, KJELLMAN G, BJORKSTÉN B. Appearance of IgE antibodies to ingested and inhaled allergens during the first 12 years of life in atopic and non-atopic children. Pediatr Allergy Immunol 1993: 4: 182-6.
34. WARNER JA, MILES EA, JONES AC, QUINT DJ, COLWELL BM, WARNER JO. Is deficiency of interferon gamma production by allergen triggered cord blood cells a predictor of atopic eczema? Clin Exp Allergy 1994: 24: 423-30.
35. JONES AC, MILES EA, WARNER JO, COLWELL BM, BRYANT TN, WARNER JA. Fetal peripheral blood mononuclear cell proliferative responses to mitogenic and allergenic stimuli during gestation. Pediatr Allergy Immunol 1996: 7: 109-16.
36. HOLT PG. Early acquisition of sensitization in childhood asthma. Pediatr Pulmonol Suppl 1995: 11: 44-6.
37. SHIOTA Y, WILSON JG, MARUKAWA M, ONO T, KAJI M. Soluble intercellular adhesion molecule 1 (ICAM-1) antigen in sera of bronchial asthmatics. Chest 1996: 109: 94-9.
38. LITTLE S, DEAN T, BEVIN S, HALL M, ASHTON M, CHURCH M, et al. Role of elevated plasma soluble ICAM-1 and bronchial lavage fluid EL-8 levels as markers of chronic disease in premature infants. Thorax 1995: 50: 1073-9.
39. BORRES MP, EINARSSON R, BJÖRKSTÉN B. Serum levels of interleukin-4, soluble CD23 and INFgamma in relation to the development of allergic disease during the first 18 months of life. Clin Exp Allergy 1995: 25: 543-8.
40. TANG ML, COLEMAN J, KEMP AS. Interleukin-4 and interferon-gamma production in atopic and non-atopic children with asthma. Clin Exp Allergy 1995: 25: 515-21.
41. RAO R, FREDERICK JM, ENANDER I, GREGSON RK, WARNER JA, WARNER JO. Airway function correlates with circulating eosinophil, but not mast cell, markers of inflammation in childhood asthma. Clin Exp Allergy 1996: 26: 789-93.
42. KRISTJÁNSSON S, SHIMIZU T, STRANNEGÅRD DL, WENNERGREN G. Eosinophil canonic protein, myeloperoxidase and tryptase in children with asthma and atopic dermatitis. Pediatr Allergy Immunol 1994: 5: 223-9.
43. PETTERSEN M, NORSETH J, CARLSEN KH. Eosinophil cationic protein (ECP) in allergic asthma, non-allergic asthma and other chronic lung diseases (CLD). Allergy 1993: 48: 90S.
44. SIGURS N, BJARNASON R, SIGURBERGSSON F. Eosinophil cationic protein in nasal secretion and in serum and myeloperoxidase in serum in respiratory syncytial virus bronchiolitis: relation to asthma and atopy. Acta Paediatr 1994: 83: 1151-5.
45. CARLSEN KH, HALVORSEN R, PETTERSEN M, LØDRUP CARLSEN KC. Inflammation markers and symptom activity in children with bronchial asthma. Influence of atopy and eczema. Pediatr Allergy Immunol 1997. In press.
46. LØDRUP CARLSEN KC, HALVORSEN R, AHLSTEDT S, CARLSEN KH. Eosinophil cationic protein and tidal volume loops in children 0-2 years of age. Eur Respir J 1995: 8: 1148-54.
47. INGRAM JM, RAKES GP, HOOVER GE, PLATTS-MILLS TA, HEYMANN PW. Eosinophil cationic protein in serum and nasal washes from wheezing infants and children. J Pediatr 1995: 127: 558-64.
48. CLOUGH JB. Markers of atopy and asthma in infancy and early childhood. In: Basomba A, Sastre J, eds. Proceedings I. XVI European Congress of allergology and clinical immunology (ECACI'95). Bologna: Monduzzi Editore, 1995: 491-4.
49. KRISTJÁNSSON S, STRANNEGÅRD IL, STRANNEGÅRD Ö, PETERSON C, ENANDER I, WENNERGREN G. Urinary eosinophil protein X in children with atopic asthma: A useful marker of antiinflammatory treatment. J Allergy Clin Immunol 1996: 97: 1179-87.